0.0130
+0.0002
+(1.56%)
As of 1:46:53 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
144.0000
174.0000
7.0000
5.0000
7.1000
Cost of Revenue
-2,472.0000
-4,931.0000
-5,272.0000
-1,375.0000
--
Gross Profit
2,616.0000
5,105.0000
5,279.0000
1,380.0000
7.1000
Operating Expense
23,729.0000
13,022.0000
10,092.0000
2,810.0000
436.9090
Operating Income
-21,113.0000
-7,917.0000
-4,813.0000
-1,430.0000
-429.8090
Net Non Operating Interest Income Expense
-584.0000
-139.0000
-2.0000
-50.0000
-10.1560
Pretax Income
-21,697.0000
-8,056.0000
-4,807.0000
-1,480.0000
-439.9650
Net Income Common Stockholders
-21,695.0000
-8,056.0000
-4,807.0000
-1,480.0000
-439.9650
Diluted NI Available to Com Stockholders
-21,695.0000
-8,056.0000
-4,807.0000
-1,480.0000
-439.9650
Basic EPS
0.51
-0.37
-0.39
-0.19
-0.03
Diluted EPS
0.51
-0.37
-0.39
-0.19
-0.03
Basic Average Shares
56,175.5570
21,540.7200
12,233.8700
13,688.0890
13,688.0890
Diluted Average Shares
86,286.1090
21,540.7200
12,233.8700
13,688.0890
13,688.0890
Total Operating Income as Reported
-21,111.0000
-7,917.0000
-4,805.0000
-1,430.0000
-3,278.4490
Total Expenses
21,257.0000
8,091.0000
4,820.0000
1,435.0000
436.9090
Net Income from Continuing & Discontinued Operation
-21,695.0000
-8,056.0000
-4,807.0000
-1,480.0000
-439.9650
Normalized Income
-21,695.0000
-8,056.0000
-4,807.0000
-1,480.0000
-439.9650
Interest Income
24.0000
24.0000
11.0000
--
--
Interest Expense
608.0000
163.0000
13.0000
50.0000
--
Net Interest Income
-584.0000
-139.0000
-2.0000
-50.0000
-10.1560
EBIT
-21,089.0000
-7,893.0000
-4,794.0000
-1,430.0000
-429.8090
EBITDA
-7,762.0000
-6,675.0000
-4,725.0000
-1,367.0000
-416.3670
Reconciled Cost of Revenue
-2,472.0000
-4,931.0000
-5,272.0000
-1,375.0000
--
Reconciled Depreciation
13,327.0000
1,218.0000
69.0000
63.0000
13.4420
Net Income from Continuing Operation Net Minority Interest
-21,695.0000
-8,056.0000
-4,807.0000
-1,480.0000
-439.9650
Normalized EBITDA
-7,762.0000
-6,675.0000
-4,725.0000
-1,367.0000
-416.3670
12/31/2020 - 4/7/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MONI.ST Monivent AB
0.3180
+1.92%
CLS-B.ST Clinical Laserthermia Systems AB (publ)
3.1800
+1.92%
QLIFE.ST Qlife Holding AB (publ)
2.1400
+0.94%
QLINEA.ST Q-linea AB (publ)
0.6700
+34.00%
OSSD.ST OssDsign AB (publ)
11.32
+0.35%
XVIVO.ST Xvivo Perfusion AB (publ)
445.00
-6.41%
ACARIX.ST Acarix AB (publ)
0.2440
-2.20%
NAYA NAYA Biosciences, Inc.
0.5000
0.00%
NUWE Nuwellis, Inc.
1.0500
+3.96%
NAOV NanoVibronix, Inc.
0.4751
-3.24%